Cargando…

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing

Liquid biopsy by genotyping circulating tumor DNA (ctDNA) has provided a non-invasive approach in assessing tumor genomic alterations in clinical oncology. However, emerging evidence in clinical settings has shown significant discordance in the genomic alterations between matched tumor tissue and bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qiaomei, Wang, Junlei, Xiao, Jianfeng, Wang, Lin, Hu, Xiaomeng, Yu, Wenjun, Song, Gang, Lou, Jiatao, Chen, JianFeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114875/ https://www.ncbi.nlm.nih.gov/pubmed/30153823 http://dx.doi.org/10.1186/s12943-018-0875-0

Ejemplares similares

DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis
por: Zhang, Chenzi, et al.
Publicado: (2017)

Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2017)

Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America
por: Salvo, Mauricio, et al.
Publicado: (2021)

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up
por: Kim, Tae-Min, et al.
Publicado: (2020)

Validation of an NGS mutation detection panel for melanoma
por: Reiman, Anne, et al.
Publicado: (2017)

Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review
por: Chen, Xiaomin, et al.
Publicado: (2020)

Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA
por: Willey, James C., et al.
Publicado: (2021)

Clinical utility of custom-designed NGS panel testing in pediatric tumors
por: Surrey, Lea F., et al.
Publicado: (2019)

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors
por: Martínez-Fernández, Paula, et al.
Publicado: (2021)

Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia
por: Ravasi, Giulia, et al.
Publicado: (2021)

What’s new in molecular genetic pathology 2021: solid tumors and NGS panel selection
por: Chen, Guoli, et al.
Publicado: (2021)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

Lung adenocarcinoma relapse with emerging EGFR mutation following complete response of small cell lung cancer warrants routine re-biopsy: A case report
por: Zhang, Minna, et al.
Publicado: (2022)

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
por: Garziera, Marica, et al.
Publicado: (2019)

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation
por: Pongor, Lőrinc, et al.
Publicado: (2017)

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow
por: Engel, Nils W., et al.
Publicado: (2020)

Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa
por: Perez-Carro, Raquel, et al.
Publicado: (2016)

Key considerations for comprehensive validation of an RNA fusion NGS panel
por: Barua, Subit, et al.
Publicado: (2020)

PanelDesign: Integrating Epidemiological Information into the Design of Diagnostic NGS Gene Panels
por: Schmidtke, Jörg, et al.
Publicado: (2022)

Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
por: Cao, Wei, et al.
Publicado: (2019)

Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
por: Lou, Jiatao, et al.
Publicado: (2013)

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016)

Corrigendum: Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa
por: Perez-Carro, Raquel, et al.
Publicado: (2016)

NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders
por: Esposito, Maria Valeria, et al.
Publicado: (2021)

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

The Army Medical Warrant
Publicado: (1876)

The Medical Warrant for India
Publicado: (1864)

Army Medical Warrant
Publicado: (1873)

The Medical Warrant for India
por: Wood, Charles
Publicado: (1865)

Warranting Dental Operations
por: Taft, J.
Publicado: (1862)

“Warranted” Dental Treatment
por: Schwamm, Henry
Publicado: (1914)

Warranting Dental Operations
Publicado: (1860)

A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer
por: Wang, Helin, et al.
Publicado: (2021)

Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics
por: Chougule, Anuradha, et al.
Publicado: (2022)

Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB(2) harmonization project comparing three NGS panels
por: Ramos-Paradas, Javier, et al.
Publicado: (2021)

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
por: Cho, Junhun, et al.
Publicado: (2021)

Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates
por: Huang, Xinwen, et al.
Publicado: (2022)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f528cn6nsutivb1q09mclkcj6c